Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Guangxi Wuzhou Zhongheng Group Co EV-to-FCF?
Guangxi Wuzhou Zhongheng Group CoSHSE:600252 -4.87%39 EV-to-FCF is 459.17 as of Jul. 17, 2026, which is 2971% above its 10-year median of 14.95. GuruFocus rates SHSE:600252 with a GF Score™ of 39/100 and a GF Value™ of ¥1.57 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 564 Drug Manufacturers companies, Guangxi Wuzhou Zhongheng Group Co ranks worse than 96.81% on this metric.
SHSE:600252'
s EV-to-FCF Range Over the Past 10 Years
Min: -266.69 Med: 14.95 Max: 1120.09
Current: 420.92
During the past 13 years, the highest EV-to-FCF of Guangxi Wuzhou Zhongheng Group Co was 1120.09. The lowest was -266.69. And the median was 14.95.
SHSE:600252's EV-to-FCF is ranked worse than 96.81% of 564
companies
in the Drug Manufacturers industry
Industry Median: 20.815
vs SHSE:600252: 420.92
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Guangxi Wuzhou Zhongheng Group Co's PE Ratio (TTM) for today is calculated as:
Guangxi Wuzhou Zhongheng Group Co's share price for today is ¥2.15.
Guangxi Wuzhou Zhongheng Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.130.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Guangxi Wuzhou Zhongheng Group Co EV-to-FCF Related Terms
Guangxi Wuzhou Zhongheng Group Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Guangxi Wuzhou Zhongheng Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangxi Wuzhou Zhongheng Group Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Guangxi Wuzhou Zhongheng Group Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Guangxi Wuzhou Zhongheng Group Co's EV-to-FCF falls into.
Guangxi Wuzhou Zhongheng Group Co's current Enterprise Value is ¥6,880 Mil.
Guangxi Wuzhou Zhongheng Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥15 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) has a EV-to-FCF of 459.17 as of Jul. 17, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Guangxi Wuzhou Zhongheng Group Co and its competitors. This is 2971% above median its historical median of 14.95. According to the industry distribution chart, Guangxi Wuzhou Zhongheng Group Co ranks #546 out of 564 companies in the Drug Manufacturers industry, placing it in the top 96.8%.
Is Guangxi Wuzhou Zhongheng Group Co's EV-to-FCF too high?
Guangxi Wuzhou Zhongheng Group Co's current EV-to-FCF of 459.17 is 2971% above median its 10-year median of 14.95. The Drug Manufacturers industry median EV-to-FCF is 20.82. Guangxi Wuzhou Zhongheng Group Co's value of 459.17 is 2106% above this industry median. Based on the distribution chart, Guangxi Wuzhou Zhongheng Group Co ranks #546 out of 564 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Guangxi Wuzhou Zhongheng Group Co has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guangxi Wuzhou Zhongheng Group Co's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Guangxi Wuzhou Zhongheng Group Co ranks #546 out of 564 companies for EV-to-FCF. This places Guangxi Wuzhou Zhongheng Group Co in the lower half of its industry. The industry median EV-to-FCF is 20.82. Guangxi Wuzhou Zhongheng Group Co's value of 459.17 is 2106% above this benchmark. While the company's 10-year median is 14.95 vs. the industry median of 20.82, Guangxi Wuzhou Zhongheng Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.82, based on 564 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangxi Wuzhou Zhongheng Group Co's current EV-to-FCF of 459.17 is 2106% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Guangxi Wuzhou Zhongheng Group Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangxi Wuzhou Zhongheng Group Co's current EV-to-FCF is 459.17, which is 2971% above median its own 10-year median of 14.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangxi Wuzhou Zhongheng Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.57, compared to a current price of ¥2.15 — trading 36.9% above its estimated fair value. The current EV-to-FCF is 459.17, which is 2971% above median its 10-year median of 14.95 and 2106% above the Drug Manufacturers industry median of 20.82. Guangxi Wuzhou Zhongheng Group Co's overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Guangxi Wuzhou Zhongheng Group Co (SHSE:600252), the current EV-to-FCF is 459.17 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) Overvalued in 2026?
Based on GuruFocus' analysis, Guangxi Wuzhou Zhongheng Group Co stock appears to be overvalued.
The current stock price of ¥2.15 is trading 36.9% above its estimated GF Value™ of ¥1.57.
GuruFocus considers Guangxi Wuzhou Zhongheng Group Co to be Significantly Overvalued.
Key valuation signals for SHSE:600252:
EV-to-FCF: 459.17 (2971% above median its 10-year median of 14.95)
GF Value™: ¥1.57 vs. price of ¥2.15 (36.9% above fair value)
Industry Position: 2106% above the Drug Manufacturers median (#546 of 564)
No single metric tells the full story. See the SHSE:600252 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangxi Wuzhou Zhongheng Group Co Business Description
Guangxi Wuzhou Zhongheng Group Co Ltd is a Chinese company engaged in the production of Chinese medicines. The company is also involved in real estate and health foods.
39GF Score
Get the complete analysis for SHSE:600252
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600252 has been successfully added to your 
